Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool-Reference-Cited by-同舟云学术

Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool

Published:2019-07-23 Issue:4 Volume:120 Page:578-586
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

den Hoven Ingrid¹,Klaveren David²,Verheuvel Nicole C.³,Parra Raquel F. D.⁴,Voogd Adri C.⁵⁶^ORCID,Roos Wilfred K.⁷,Bosscha Koop⁸,Heuts Esther M.⁹,Tjan‐Heijnen Vivianne C. G.¹⁰,Roumen Rudi M. H.¹⁵,Steyerberg Ewout W.²

Affiliation:

1. Department of Surgery Máxima Medical Center Veldhoven The Netherlands

2. Department of Public Health Center for Medical Decision Sciences Erasmus MC Rotterdam The Netherlands

3. Department of Surgery Elisabeth‐TweeSteden Hospital Tilburg The Netherlands

4. Division of Surgery Department of Breast Surgical Oncology The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Research Netherlands Comprehensive Cancer Organization (IKNL) Utrecht The Netherlands

6. Department of Epidemiology School for Oncology and Developmental Biology (GROW) Maastricht University Medical Center Maastricht The Netherlands

7. Department of Surgery Gelderse Vallei Hospital Ede The Netherlands

8. Department of Surgery Jeroen Bosch Hospital Den Bosch The Netherlands

9. Department of Surgery School for Oncology and Developmental Biology (GROW) Maastricht University Medical Centre Maastricht The Netherlands

10. Department of Medical Oncology School for Oncology and Developmental Biology (GROW) Maastricht University Medical Center Maastricht The Netherlands

Funder

Netherlands Organization for Scientific Research

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jso.25644

Reference28 articles.

1. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

2. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the american college of surgeons oncology group Z0011 randomized trial;Giuliano AE;Ann Surg,2010

3. Radiotherapy or surgery for the axilla in node-positive breast cancer? – Authors' reply

4. Two decades of axillary management in breast cancer

5. The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Validation of Nomograms to Predict Risk and Prognosis in Salivary Gland Carcinoma Patient with Distant Metastases;Ear, Nose & Throat Journal;2023-12-03

2. Development and Validation of a Prognostic Model for Overall Survival in Patients with Primary Pelvis and Spine Osteosarcoma: A Population-Based Study and External Validation;Journal of Clinical Medicine;2023-03-27

3. Crafting a prognostic nomogram for the overall survival rate of cutaneous verrucous carcinoma using the surveillance, epidemiology, and end results database;Frontiers in Endocrinology;2023-03-27

4. A web-based prognostic nomogram for the cancer specific survival of elderly patients with T1-T3N0M0 renal pelvic transitional cell carcinoma based on the surveillance, epidemiology, and end results database;BMC Urology;2022-05-24

5. Elaboration and Validation of a Nomogram Based on Axillary Ultrasound and Tumor Clinicopathological Features to Predict Axillary Lymph Node Metastasis in Patients With Breast Cancer;Frontiers in Oncology;2022-05-16